BMS-986454

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Healthy ParticipantsRheumatoid Arthritis

Phase 1

A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants

CompletedNCT06086886

Bristol-Myers SquibbHealthy Participants

Start: 2023-11-16End: 2024-12-20Updated: 2025-03-24

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

RecruitingNCT07171983

Bristol-Myers SquibbRheumatoid Arthritis

Start: 2026-02-27End: 2027-08-25Target: 46Updated: 2026-07-20